325 related articles for article (PubMed ID: 17530572)
1. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.
Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
Neurol Neurochir Pol; 2007; 41(2):113-21. PubMed ID: 17530572
[TBL] [Abstract][Full Text] [Related]
2. The role of NAT2 gene polymorphism in aetiology of the most frequent neurodegenerative diseases with dementia.
Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
Neurol Neurochir Pol; 2007; 41(5):388-94. PubMed ID: 18033638
[TBL] [Abstract][Full Text] [Related]
3. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
4. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.
Atkinson A; Singleton AB; Steward A; Ince PG; Perry RH; McKeith IG; Fairbairn AF; Edwardson JA; Daly AK; Morris CM
Pharmacogenetics; 1999 Feb; 9(1):31-5. PubMed ID: 10208640
[TBL] [Abstract][Full Text] [Related]
5. No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.
Scordo MG; Dahl ML; Spina E; Cordici F; Arena MG
Pharmacol Res; 2006 Feb; 53(2):162-5. PubMed ID: 16337409
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].
Durić G; Svetel M; Nikolaevic SI; Dragadević N; Gavrilović J; Kostić VS
Vojnosanit Pregl; 2007 Jan; 64(1):25-30. PubMed ID: 17304721
[TBL] [Abstract][Full Text] [Related]
8. CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population.
Woo SI; Kim JW; Seo HG; Park CH; Han SH; Kim SH; Kim KW; Jhoo JH; Woo JI
Psychiatry Clin Neurosci; 2001 Aug; 55(4):373-7. PubMed ID: 11442888
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease and mixed dementia: a one-year naturalistic study.
Miranda LF; Gomes KB; Silveira JN; Pianetti GA; Byrro RM; Peles PR; Pereira FH; Santos TR; Assini AG; Ribeiro VV; Tito PA; Matoso RO; Lima TO; Moraes EN; Caramelli P
J Alzheimers Dis; 2015; 45(2):609-20. PubMed ID: 25589728
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.
Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT
J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621
[TBL] [Abstract][Full Text] [Related]
11. ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guam.
Chen X; Xia Y; Gresham LS; Molgaard CA; Thomas RG; Galasko D; Wiederholt WC; Saitoh T
Neurology; 1996 Sep; 47(3):779-84. PubMed ID: 8797479
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of apolipoprotein E genotype in Parkinson disease patients with and without dementia].
Jasińska-Myga B; Opala G; Ochudło S; Tustanowski J
Wiad Lek; 2004; 57(1-2):20-4. PubMed ID: 15181744
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
Bialecka M; Klodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Safranow K; Droździk M
Parkinsonism Relat Disord; 2007 May; 13(4):224-9. PubMed ID: 17270484
[TBL] [Abstract][Full Text] [Related]
14. Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.
Devos D; Lejeune S; Cormier-Dequaire F; Tahiri K; Charbonnier-Beaupel F; Rouaix N; Duhamel A; Sablonnière B; Bonnet AM; Bonnet C; Zahr N; Costentin J; Vidailhet M; Corvol JC
Parkinsonism Relat Disord; 2014 Feb; 20(2):170-5. PubMed ID: 24216088
[TBL] [Abstract][Full Text] [Related]
15. Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease.
Santt O; Baranova H; Albuisson E; Bignon YJ; Lucotte G
Eur J Neurol; 2004 Apr; 11(4):247-51. PubMed ID: 15061826
[TBL] [Abstract][Full Text] [Related]
16. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
17. Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease.
Tanaka S; Chen X; Xia Y; Kang DE; Matoh N; Sundsmo M; Thomas RG; Katzman R; Thal LJ; Trojanowski JQ; Saitoh T; Ueda K; Masliah E
Neurology; 1998 Jun; 50(6):1556-62. PubMed ID: 9633694
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease.
Diederich N; Hilger C; Goetz CG; Keipes M; Hentges F; Vieregge P; Metz H
Ann Neurol; 1996 Sep; 40(3):463-5. PubMed ID: 8797539
[TBL] [Abstract][Full Text] [Related]
19. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of L-dopa-induced adverse effects.
Pascale E; Purcaro C; Passarelli E; Guglielmi R; Vestri AR; Passarelli F; Meco G
J Neurol Sci; 2009 Jan; 276(1-2):18-21. PubMed ID: 18805557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
